Global Stocks

Bunge Global (BG) After The Zacks Upgrade And Rising Estimates Looks Undervalued

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.

Bunge Global (BG) drew fresh attention after receiving a Zacks Rank #2 upgrade, with analysts lifting earnings estimates over the past 3 months. This shift has coincided with renewed interest in the stock.

See our latest analysis for Bunge Global.

At a share price of $114.32, Bunge Global has seen its 7-day share price return of 7.38% partly offset earlier weakness, with the 30-day share price return down 10.83%, while the 1-year total shareholder return is 53.17%, indicating momentum that has built over a longer period.

If this kind of rerating has you thinking about what else is moving, it could be a good moment to broaden your search with 18 top founder-led companies

After a strong year for Bunge Global and a sharp recent swing, the question is whether the current price still offers attractive upside for the risk involved. The valuation numbers provide the next clue.

Most Popular Narrative: 19.5% Undervalued

Compared with Bunge Global’s last close of $114.32, the most popular narrative assigns a fair value of $142.00, suggesting a wide gap that hinges on growth, margins, and cash returns to shareholders.

The completion and integration of the Viterra merger provides substantial cost and commercial synergies, expands Bunge’s global origination, processing, and distribution footprint, and positions the company to capture greater market share in high-growth markets, which is set to drive higher topline growth and improved operating margins.

Read the complete narrative.

Curious what sits behind that confidence in Bunge Global? The narrative leans heavily on a step up in earnings power, a richer product mix, and a lower future earnings multiple than many investors might expect.

Result: Fair Value of $142.00 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, investors in Bunge Global still need to weigh regulatory changes in key biofuel markets, as well as the execution risk around the Viterra integration potentially delaying expected benefits.

Find out about the key risks to this Bunge Global narrative.

Another View on Bunge Global’s Valuation

The community narrative points to a fair value of $142.00 for Bunge Global, but the current P/E of 32.3x tells a different story. That multiple is higher than the US Food industry average of 18.1x and above peer levels around 26.9x, while our fair ratio is 49.1x.

In practice, that mix of numbers means the stock is priced richer than many industry and peer comparisons, yet still below where the fair ratio suggests the P/E could move over time. For investors, the tension is whether this represents valuation risk if sentiment cools, or an opening if earnings grow into that gap.

To see how those earnings and multiples line up in detail, take a closer look at the valuation breakdown with See what the numbers say about this price — find out in our valuation breakdown.

NYSE:BG P/E Ratio as at Jul 2026

Next Steps

If this mix of optimism and concern around Bunge Global has you thinking hard about the next move, now is the time to test the numbers, read the narratives and weigh both sides with 3 key rewards and 3 important warning signs

Looking for more investment ideas beyond Bunge Global?

Do not stop with Bunge Global. Use these focused stock ideas to pressure test your thinking and spot opportunities you might otherwise miss.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include BG.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button